We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




IL-1 Regulates Bone Density

By Biotechdaily staff writers
Posted on 14 Sep 2005
Researchers seeking to understand the factors that lead to loss of bone density and development of osteoporosis have found that interleukin-1 (IL-1) produced in the brain is linked to an increase in the number and activity of the multinucleated cells that degrade and reabsorb bone, called osteoclastic cells.

Investigators at the Hebrew University of Jerusalem (Israel) worked with two lines of mice genetically engineered to have defects in brain-generated IL-1. More...
They found that mice of the IL-1rKO line, which lacked the gene for IL-1, had abnormally low bone density. The second line (IL-1raTG) had normal bone density, but could be made to develop osteoporosis by inducing the mice to overexpress human IL-1 receptor antagonist to the central nervous system using the murine glial fibrillary acidic protein promoter. These findings were published in the August 26, 2005, online edition of the Proceedings of the [U.S.] National Academy of Sciences.

"The connection between the brain and the bone structure is a new area of research about which very little is known,” said senior author Professor Itai Bab, director of the bone laboratory at the Hebrew University of Jerusalem. "These new findings regarding the action of interleukin-1 on the breakdown of bone tissue indicate a complex neural system controlling bone structure and point the way towards new revelations in the near future in this area.”




Related Links:
Hebrew University of Jerusalem

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.